Literature DB >> 31309595

Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction.

Xiao Jing Wang1, Michael Camilleri1, Stephen Vanner2, Caroline Tuck2.   

Abstract

BACKGROUND: Due to the paucity of targeted therapy for irritable bowel syndrome (IBS), many patients turn to dietary modifications for symptom management. The combination of five subgroups of poorly absorbed and rapidly fermented carbohydrates-fructans, galacto-oligosaccharides, lactose, excess fructose and polyols-are thought to trigger gastrointestinal symptoms and are referred to collectively as "FODMAPs". AIMS: To examine the biological plausibility and mechanisms by which foods high in specific FODMAP subgroups cause symptoms, and to use this information to explore the possibility of targeting select dietary components to allow for a more personalised approach to dietary adjustment
METHODS: Recent literature was analysed via search databases including Medline, PubMed and Scopus.
RESULTS: Lactose, fructans and galacto-oligosaccharides have strong biologic plausibility for symptom generation due to lack of hydrolases resulting in distention from osmosis and rapid fermentation. However, excess fructose and polyols may only cause symptoms in specific individuals when consumed in high doses, but this remains to be established. There is evidence to suggest that certain patient characteristics such as ethnicity may predict response to lactose, but differentiation of other subgroups is difficult prior to dietary manipulation.
CONCLUSIONS: While some clear mechanisms of action for symptom generation have been established, further research is needed to understand which patients will respond to specific FODMAP subgroup restriction. We suggest that clinicians consider in some patients a tailored, personalised "bottom-up" approach to the low-FODMAP diet, such as dietary restriction relevant to the patients' ethnicity, symptom profile and usual dietary intake.
© 2019 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31309595     DOI: 10.1111/apt.15419

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  10 in total

Review 1.  How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.

Authors:  Nessmah Sultan; Jane E Varney; Emma P Halmos; Jessica R Biesiekierski; Chu K Yao; Jane G Muir; Peter R Gibson; Caroline J Tuck
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 2.  Carbohydrate Maldigestion and Intolerance.

Authors:  Fernando Fernández-Bañares
Journal:  Nutrients       Date:  2022-05-04       Impact factor: 6.706

3.  FODMAP Intake in Spanish Population: Open Approach for Risk Assessment.

Authors:  Jonatan Miranda; Maialen Vázquez-Polo; Gesala Pérez-Junkera; María Del Pilar Fernández-Gil; María Ángeles Bustamante; Virginia Navarro; Edurne Simón; Olaia Martínez
Journal:  Int J Environ Res Public Health       Date:  2020-08-13       Impact factor: 3.390

4.  An algorithm for differentiating food antigen-related gastrointestinal symptoms.

Authors:  Kamran Rostami; Justine Bold; Jafer Ismail Ali; Alison Parr; Walburga Dieterich; Yurdagül Zopf; Aung Htoo; Mohammad Rostami-Nejad; Mihai Danciu
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

5.  Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial.

Authors:  Elise Nordin; Carl Brunius; Rikard Landberg; Per M Hellström
Journal:  Am J Clin Nutr       Date:  2022-02-09       Impact factor: 7.045

6.  The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.

Authors:  Prashant Singh; Caroline Tuck; Peter R Gibson; William D Chey
Journal:  Am J Gastroenterol       Date:  2022-04-08       Impact factor: 12.045

7.  Diet and irritable bowel syndrome: an update from a UK consensus meeting.

Authors:  A Rej; A Avery; I Aziz; C J Black; R K Bowyer; R L Buckle; L Seamark; C C Shaw; J Thompson; N Trott; M Williams; D S Sanders
Journal:  BMC Med       Date:  2022-09-13       Impact factor: 11.150

Review 8.  Orthorexia nervosa is a concern in gastroenterology: A scoping review.

Authors:  Caroline J Tuck; Nessmah Sultan; Matilda Tonkovic; Jessica R Biesiekierski
Journal:  Neurogastroenterol Motil       Date:  2022-07-10       Impact factor: 3.960

9.  A Gluten Reduction Is the Patients' Choice for a Dietary 'Bottom Up' Approach in IBS-A Comment on "A 5Ad Dietary Protocol for Functional Bowel Disorders" Nutrients 2019, 11, 1938.

Authors:  Christian Charles Shaw; Rachel Louise Buckle; Anupam Rej; Nick Trott; Imran Aziz; David Surendran Sanders
Journal:  Nutrients       Date:  2020-01-03       Impact factor: 5.717

10.  Long-Term Effect of a Gluten-Free Diet on Diarrhoea- or Bloating-Predominant Functional Bowel Disease: Role of the 'Low-Grade Coeliac Score' and the 'Coeliac Lymphogram' in the Response Rate to the Diet.

Authors:  Fernando Fernández-Bañares; Beatriz Arau; Agnès Raga; Montserrat Aceituno; Eva Tristán; Anna Carrasco; Laura Ruiz; Albert Martín-Cardona; Pablo Ruiz-Ramírez; Maria Esteve
Journal:  Nutrients       Date:  2021-05-26       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.